BioSpace News Archive

Mesoblast Limited, global leader in cellular medicines for inflammatory diseases, announced that the United States Food and Drug Administration has confirmed receipt of Mesoblast’s filing of clinical efficacy and safety data for remestemcel-L in its rolling Biologics License Application for the treatment of children with steroid-refractory acute graft versus host disease.

Exact Sciences Corp. announced that company management will participate in the following investor conference and invited investors to participate by webcast.

The company will provide an overview of the business and discuss recent corporate achievements that position it to further extend its leadership in the market.

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, and Dr. Roger M. Perlmutter, president, Merck Research Laboratories, are scheduled to participate at the 38th Annual J.P. Morgan Healthcare Conference

Alston & Bird, with over 800 attorneys, has offices in Atlanta, Beijing, Brussels, Charlotte, Dallas, London, Los Angeles, New York, Raleigh, San Francisco, Silicon Valley, and Washington, D.C.

Conference on Tuesday, January 14, 2020 at 3:30 p.m. PT in San Francisco, CA.

The conference will be held at the Westin St. Francis Hotel in San Francisco, CA.

The conference will take place on January 14-15 2020 at the Lotte New York Palace Hotel.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Matthew K. Harbaugh as executive vice president and chief financial officer (CFO) effective immediately.